Azure Biotech: David Thompson, PhD to Lead Azure Biotech as President / Company Prepares to Enter Clinical Studies for Vulvovaginal Atrophy (VVA)

GALES FERRY, CT--(Marketwired - March 08, 2016) - Azure Biotech, Inc. a private biotechnology company developing novel formulations of lasofoxifene announced today that David Thompson, PhD will le...